Literature DB >> 33372603

Plasma levels of the active form of suPAR are associated with COVID-19 severity.

Mingxiang Huang1, Linlin Li2, Jianshan Shen1, Yao Wang1, Rui Wang1, Cai Yuan3, Mingdong Huang4, Longguang Jiang5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33372603      PMCID： PMC7770382          DOI： 10.1186/s13054-020-03336-0

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


× No keyword cloud information.
  7 in total

1.  Structure of human urokinase plasminogen activator in complex with its receptor.

Authors:  Qing Huai; Andrew P Mazar; Alice Kuo; Graham C Parry; David E Shaw; Jennifer Callahan; Yongdong Li; Cai Yuan; Chuanbing Bian; Liqing Chen; Bruce Furie; Barbara C Furie; Douglas B Cines; Mingdong Huang
Journal:  Science       Date:  2006-02-03       Impact factor: 47.728

2.  An ELISA method detecting the active form of suPAR.

Authors:  Xiaolei Zhou; Mingming Xu; Hailong Huang; Andrew Mazar; Zafar Iqbal; Cai Yuan; Mingdong Huang
Journal:  Talanta       Date:  2016-07-04       Impact factor: 6.057

3.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R.

Authors:  M Resnati; I Pallavicini; J M Wang; J Oppenheim; C N Serhan; M Romano; F Blasi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

4.  High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients.

Authors:  Sisse Rye Ostrowski; Timo Piironen; Gunilla Høyer-Hansen; Jan Gerstoft; Bente Klarlund Pedersen; Henrik Ullum
Journal:  J Acquir Immune Defic Syndr       Date:  2005-05-01       Impact factor: 3.731

5.  Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.

Authors:  Tariq U Azam; Husam R Shadid; Pennelope Blakely; Patrick O'Hayer; Hanna Berlin; Michael Pan; Peiyao Zhao; Lili Zhao; Subramaniam Pennathur; Rodica Pop-Busui; Izzet Altintas; Jens Tingleff; Marius A Stauning; Ove Andersen; Maria-Evangelia Adami; Nicky Solomonidi; Maria Tsilika; Pinkus Tober-Lau; Eleni Arnaoutoglou; Verena Keitel; Frank Tacke; Athanasios Chalkias; Sven H Loosen; Evangelos J Giamarellos-Bourboulis; Jesper Eugen-Olsen; Jochen Reiser; Salim S Hayek
Journal:  J Am Soc Nephrol       Date:  2020-09-22       Impact factor: 10.121

Review 6.  COVID-19 and pneumonia: a role for the uPA/uPAR system.

Authors:  Daniele D'Alonzo; Maria De Fenza; Vincenzo Pavone
Journal:  Drug Discov Today       Date:  2020-06-18       Impact factor: 7.851

7.  Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia.

Authors:  Nikoletta Rovina; Karolina Akinosoglou; Jesper Eugen-Olsen; Salim Hayek; Jochen Reiser; Evangelos J Giamarellos-Bourboulis
Journal:  Crit Care       Date:  2020-04-30       Impact factor: 9.097
  7 in total
  6 in total

1.  SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome.

Authors:  Emanuela Galliera; Luca Massaccesi; Lina Yu; Jianwen He; Marco Ranucci; Massimiliano M Corsi Romanelli
Journal:  Biomolecules       Date:  2022-06-13

Review 2.  suPAR: An Inflammatory Mediator for Kidneys.

Authors:  Yashwanth Reddy Sudhini; Changli Wei; Jochen Reiser
Journal:  Kidney Dis (Basel)       Date:  2022-06-08

3.  Comparison of the Mortality Prediction Value of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in COVID-19 and Sepsis.

Authors:  Alice G Vassiliou; Alexandros Zacharis; Charikleia S Vrettou; Chrysi Keskinidou; Edison Jahaj; Zafeiria Mastora; Stylianos E Orfanos; Ioanna Dimopoulou; Anastasia Kotanidou
Journal:  Diagnostics (Basel)       Date:  2022-05-18

4.  Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19.

Authors:  Helena Enocsson; Cornelia Idoff; Annette Gustafsson; Melissa Govender; Francis Hopkins; Marie Larsson; Åsa Nilsdotter-Augustinsson; Johanna Sjöwall
Journal:  Front Med (Lausanne)       Date:  2021-12-02

5.  Soluble urokinase plasminogen activator receptor levels are predictive of COVID-19 severity in Afro-Caribbean patients.

Authors:  Mael Padelli; Papa Gueye; Diane Guilloux; Rishika Banydeen; Valentine Campana; Andre Cabie; Remi Neviere
Journal:  Biomark Med       Date:  2022-01-27       Impact factor: 2.851

Review 6.  suPAR to Risk-Stratify Patients With Malaria.

Authors:  Veselina Stefanova; Valerie M Crowley; Andrea M Weckman; Kevin C Kain
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.